Maxwell Stock grew up in the lab where he first became enamored with science and the idea of helping people improve their health using science-based approaches. Author of numerous patents, scientific publications, and founder of Signum Biosciences he utilizes this scientific foundation to guide Signum’s product development and commercialization.   After more than 20 years of developing topical drugs and cosmetic ingredients in the pharmaceutical and cosmetic industries, Max and his team created Epicutis to bring a new paradigm to skincare through clean and minimalist formulations with highly efficacious patented ingredients focused on skin health not age.